60 Pre-clinical evaluation of combinations of PI3K & MEK inhibitors in colorectal carcinoma cell lines
Emma J. Cox, David R. Newell(Newcastle University), Spencer Kyle, Gary Beale(Epistem (United Kingdom)), Ramona Maxwell
Cited by 0
Related Papers
Tumour necrosis factor in man: Clinical and biological observations
|British Journal of Cancer|1987|203
The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease
|Gastroenterology|2008|196
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
|British Journal of Cancer|2011|193
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
|BMC Cancer|2008|125
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
|British Journal of Cancer|2012|83